STAT3 and Hepatic fibrosis: Interleukin (IL)-17A inhibits autophagy by activating STAT3 in hepatic fibrosis; in turn, STAT3 downregulates the expression of BECN1 and VPS34, which are involved in the development of hepatic fibrosis132.